Annual Total Expenses
$81.41 M
+$28.17 M+52.92%
December 31, 2023
Summary
- As of February 8, 2025, AVTE annual total expenses is $81.41 million, with the most recent change of +$28.17 million (+52.92%) on December 31, 2023.
- During the last 3 years, AVTE annual total expenses has risen by +$72.52 million (+815.84%).
- AVTE annual total expenses is now at all-time high.
Performance
AVTE Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$17.41 M
-$8.76 M-33.46%
September 30, 2024
Summary
- As of February 8, 2025, AVTE quarterly total expenses is $17.41 million, with the most recent change of -$8.76 million (-33.46%) on September 30, 2024.
- Over the past year, AVTE quarterly total expenses has dropped by -$4.66 million (-21.10%).
- AVTE quarterly total expenses is now -33.46% below its all-time high of $26.16 million, reached on June 30, 2024.
Performance
AVTE Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
AVTE Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +52.9% | -21.1% |
| 3 y3 years | +815.8% | -21.1% |
| 5 y5 years | +2344.0% | -21.1% |
AVTE Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +253.6% | -33.5% | +110.6% |
| 5 y | 5-year | at high | +2344.0% | -33.5% | +1182.0% |
| alltime | all time | at high | +2344.0% | -33.5% | +1182.0% |
Aerovate Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $17.41 M(-33.5%) |
| Jun 2024 | - | $26.16 M(+6.3%) |
| Mar 2024 | - | $24.62 M(+11.6%) |
| Dec 2023 | $81.41 M(+52.9%) | $22.07 M(+3.3%) |
| Sep 2023 | - | $21.37 M(+5.1%) |
| Jun 2023 | - | $20.34 M(+15.3%) |
| Mar 2023 | - | $17.64 M(+11.3%) |
| Dec 2022 | $53.24 M | $15.85 M(+12.0%) |
| Sep 2022 | - | $14.15 M(+15.9%) |
| Jun 2022 | - | $12.21 M(+10.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $11.02 M(+33.3%) |
| Dec 2021 | $23.02 M(+159.0%) | $8.27 M(+33.4%) |
| Sep 2021 | - | $6.20 M(+7.4%) |
| Jun 2021 | - | $5.77 M(+107.7%) |
| Mar 2021 | - | $2.78 M(-24.1%) |
| Dec 2020 | $8.89 M(+166.9%) | $3.66 M(+63.3%) |
| Sep 2020 | - | $2.24 M(+38.0%) |
| Jun 2020 | - | $1.63 M(+19.7%) |
| Mar 2020 | - | $1.36 M |
| Dec 2019 | $3.33 M | - |
FAQ
- What is Aerovate Therapeutics annual total expenses?
- What is the all time high annual total expenses for Aerovate Therapeutics?
- What is Aerovate Therapeutics annual total expenses year-on-year change?
- What is Aerovate Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Aerovate Therapeutics?
- What is Aerovate Therapeutics quarterly total expenses year-on-year change?
What is Aerovate Therapeutics annual total expenses?
The current annual total expenses of AVTE is $81.41 M
What is the all time high annual total expenses for Aerovate Therapeutics?
Aerovate Therapeutics all-time high annual total expenses is $81.41 M
What is Aerovate Therapeutics annual total expenses year-on-year change?
Over the past year, AVTE annual total expenses has changed by +$28.17 M (+52.92%)
What is Aerovate Therapeutics quarterly total expenses?
The current quarterly total expenses of AVTE is $17.41 M
What is the all time high quarterly total expenses for Aerovate Therapeutics?
Aerovate Therapeutics all-time high quarterly total expenses is $26.16 M
What is Aerovate Therapeutics quarterly total expenses year-on-year change?
Over the past year, AVTE quarterly total expenses has changed by -$4.66 M (-21.10%)